Androstenedione
CAS 63-05-8
Androstenedione (CAS 63-05-8) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 29961.977966101695 nM | 43 | - |
| - | IC50 | 9489.791333333333 nM | 14 | - |
| - | Ki | 597.6 nM | 3 | - |
| - | AC50 | 25118.9 nM | 2 | - |
| - | Kd | 34.67 nM | 1 | - |
| Aromatase Enzyme |
Ki | 7.7 | - | Homo sapiens |
| Corticosteroid-binding globulin Secreted |
Ki | 5.76 | - | Homo sapiens |
| Sex hormone-binding globulin Secreted |
Kd | 7.46 | - | Homo sapiens |
| Testosterone 17-beta-dehydrogenase 3 Enzyme |
IC50 | 6.31 | - | Homo sapiens |
| Androgen receptor Transcription factor |
IC50 | 5.89 | - | Rattus norvegicus |
| Testosterone 17-beta-dehydrogenase 3 Enzyme |
IC50 | 6.77 | - | Rattus norvegicus |
| Alpha-synuclein Transporter |
IC50 | 4.07 | - | Homo sapiens |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| Androgen receptor Ar |
Agonist | 8.56 pIC50 | 14565775 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Androstenedione used for in pharmaceutical contexts?
Androstenedione (CAS 63-05-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Androstenedione?
No adverse-event association or SIDER side-effect rows are rendered for Androstenedione in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Androstenedione also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Androstenedione with EU status "prohibited".
What clinical phase is Androstenedione in?
No phase 1-4 clinical development badge is rendered for Androstenedione because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Androstenedione?
Androstenedione has 12 bioactivity rows in this page query. Rendered target entries include Aromatase, Corticosteroid-binding globulin, Sex hormone-binding globulin, Testosterone 17-beta-dehydrogenase 3, Androgen receptor.